Table 1 Patient basic baseline characteristics
Patient # | Age at diagnosis | PSA (ng/mL) | Gleason (primary + secondary) | Risk group |
|---|---|---|---|---|
1 | 60 | 9.2 | 3 + 4 | 2 |
2 | 58 | 9.7 | 3 + 4 | 2 |
3 | 60 | 10.9 | 3 + 3 | 2 |
4 | 55 | 8.6 | 4 + 3 | 2 |
5 | 55 | 9.2 | 3 + 3 | 1 |
6 | 51 | 8.7 | 3 + 4 | 2 |
7 | 54 | 6.7 | 4 + 3 | 2 |
8 | 74 | 7.4 | 4 + 3 | 2 |
9 | 57 | 7.7 | 3 + 4 | 2 |
10 | 65 | 14.5 | 4 + 3 | 2 |
11 | 53 | 3.9 | 3 + 4 | 2 |
12 | 57 | 11.6 | 3 + 4 | 2 |